LentiMPH v2 vector (V016743)

Price Information

Cat No. Plasmid Name Availability Add to cart
V016743 LentiMPH v2 In stock, instant shipping

Buy one, get one free!

Two tubes of lyophilized plasmid will be delivered, each tube is about 5µg.

Basic Vector Information

lentiMPH v2 is a lenti vector encoding the MS2-P65-HSF1 activator helper complex with a 2A Hygro resistance marker (EF1a-MS2-p65-HSF1-2A-Hygro-WPRE). This version has a higher virus titer than the first one.

Vector Name:
LentiMPH v2
Antibiotic Resistance:
Ampicillin
Length:
11739 bp
Type:
Gene knockout
Replication origin:
ori
Host:
Mammalian cells, Lentivirus
Selection Marker:
Hyg,Zeo
Promoter:
EF-1α
Growth Strain(s):
Stbl3
Growth Temperature:
37℃

LentiMPH v2 vector Map

LentiMPH v211739 bp50010001500200025003000350040004500500055006000650070007500800085009000950010000105001100011500HIV-1 Psi5' LTR (truncated)CMV promoterCMV enhancerAmpR promoterAmpRoriCAP binding sitelac promoterSV40 poly(A) signalBleoREM7 promoterSV40 promoterf1 oribGH poly(A) signal5' LTR (truncated)EF-1-alpha promoterMS2-N55Kp65HSF1T2AHygRWPREcPPT/CTSProtein Tatgp41 peptideRRE

Plasmid Protocol

1. Centrifuge at 5,000×g for 5 min.

2. Carefully open the tube and add 20 μl of sterile water to dissolve the DNA.

3. Close the tube and incubate for 10 minutes at room temperature.

4. Briefly vortex the tube and then do a quick spin to concentrate the liquid at the bottom. Speed is less than 5000×g.

5. Store the plasmid at -20 ℃.

6. The concentration of plasmid re-measurement sometimes differs from the nominal value, which may be due to the position of the lyophilized plasmid in the tube, the efficiency of the re-dissolution, the measurement bias, and adsorption on the wall of the tube, therefore, it is recommended to transform and extract the plasmid before using it

General Plasmid Transform Protocol

1. Take one 100μl of the competent cells and thaw it on ice for 10min, add 2μl of plasmid, then ice bath for 30min, then heat-shock it at 42℃ for 60s, do not stir, and then ice bath for 2min.

2. Add 900μl of LB liquid medium without antibiotics, and incubate at 37℃ for 45min (30℃ for 1-1.5 hours) with 180rpm shaking.

3. Centrifuge at 6000rpm for 5min, leave only 100μl of supernatant to resuspend the bacterial precipitate and spread it onto the target plasmid-resistant LB plate.

4. Invert the plate and incubate at 37℃ for 14h, or at 30℃ for 20h.

5. Pick a single colony into LB liquid medium, add the corresponding antibiotics, incubate at 220rpm for 14h, and extract the plasmid according to the experimental needs and the instructions of the plasmid extraction kit.

References

  • Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2017 Apr;12(4):828-863.

LentiMPH v2 vector Sequence

LOCUS       V016743                11739 bp    DNA     circular SYN 01-JAN-1980
DEFINITION  Exported.
ACCESSION   V016743
VERSION     V016743
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 11739)
  AUTHORS   .
  TITLE     Direct Submission
FEATURES             Location/Qualifiers
     source          1..11739
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     misc_feature    complement(488..613)
                     /label="HIV-1 Psi"
                     /note="packaging signal of human immunodeficiency virus
                     type 1"
     LTR             complement(660..840)
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     promoter        complement(855..1057)
                     /label="CMV promoter"
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     enhancer        complement(1058..1437)
                     /label="CMV enhancer"
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        1703..1807
                     /label="AmpR promoter"
     CDS             1808..2665
                     /label="AmpR"
                     /note="beta-lactamase"
     rep_origin      2839..3427
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     protein_bind    3715..3736
                     /label="CAP binding site"
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     promoter        3751..3781
                     /label="lac promoter"
                     /note="promoter for the E. coli lac operon"
     polyA_signal    complement(3866..3999)
                     /label="SV40 poly(A) signal"
                     /note="SV40 polyadenylation signal"
     CDS             complement(4132..4503)
                     /label="BleoR"
                     /note="antibiotic-binding protein"
     promoter        complement(4522..4569)
                     /label="EM7 promoter"
                     /note="synthetic bacterial promoter"
     promoter        complement(4617..4946)
                     /label="SV40 promoter"
                     /note="SV40 enhancer and early promoter"
     rep_origin      complement(4960..5388)
                     /direction=LEFT
                     /label="f1 ori"
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"
     polyA_signal    complement(5434..5658)
                     /label="bGH poly(A) signal"
                     /note="bovine growth hormone polyadenylation signal"
     LTR             complement(5690..5870)
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     promoter        6475..7653
                     /label="EF-1-alpha promoter"
                     /note="strong constitutive promoter for human elongation
                     factor EF-1-alpha"
     CDS             7669..8055
                     /label="MS2-N55K"
                     /note="bacteriophage MS2 coat protein"
     CDS             8146..8688
                     /label="p65"
                     /note="C-terminal portion of the p65 subunit of mouse
                     NF-kappa-B"
     CDS             8713..9084
                     /label="HSF1"
                     /note="C-terminal activation domain from the human heat
                     shock transcription factor HSF1"
     CDS             9100..9153
                     /label="T2A"
                     /note="2A peptide from Thosea asigna virus capsid protein"
     CDS             9157..10179
                     /label="HygR"
                     /note="aminoglycoside phosphotransferase from E. coli"
     misc_feature    10216..10804
                     /label="WPRE"
                     /note="woodchuck hepatitis virus posttranscriptional
                     regulatory element"
     misc_feature    complement(10857..10974)
                     /label="cPPT/CTS"
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"
     CDS             complement(11082..11123)
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate WMJ22). Accession#: P12509"
                     /label="Protein Tat"
     CDS             complement(11272..11316)
                     /label="gp41 peptide"
                     /note="antigenic peptide corresponding to amino acids 655
                     to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
                     al., 2013)"
     misc_feature    complement(11501..11734)
                     /label="RRE"
                     /note="The Rev response element (RRE) of HIV-1 allows for
                     Rev-dependent mRNA export from the nucleus to the
                     cytoplasm."